EDITAS MEDICINE INC.
3.1700
07-November-24 15:59:58
15 minutes delayed
Stocks
-0.1100
-3.35%
Today's range
3.1100 - 3.3000
ISIN
N/A
Source
NASDAQ
-
07 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
30 Sep 2021 08:00:00 By Nasdaq GlobeNewswire
-
29 Sep 2021 09:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Emma Reeve to Board of Directors
08 Sep 2021 09:00:01 By Nasdaq GlobeNewswire
-
07 Sep 2021 16:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
02 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
20 Aug 2021 16:20:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2021 Results and Business Updates
04 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update
28 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
26 Jul 2021 09:00:00 By Nasdaq GlobeNewswire
-
23 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2021 16:01:00 By Nasdaq GlobeNewswire
-
14 Jun 2021 09:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Announces First Quarter 2021 Results and Update
05 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer
05 May 2021 06:59:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update
28 Apr 2021 07:01:00 By Nasdaq GlobeNewswire